Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NRIX
#1905
Nurix Therapeutics, Inc. Common stock
15.970
0
+2.70%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+2.70%
Monthly Change
-18.42%
6 month change
+42.46%
Year Change
+42.46%
Previous Close
15.550
0
Open
15.970
0
Bid
Ask
Low
15.970
0
High
15.970
0
Volume
162
Markets
US Stock Market
Healthcare
NRIX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
0
—
—
—
0
0
0
Dividend yield %
0
—
—
—
0
0
0
Payout ratio %
—
—
—
—
0
0
0
News
Nurix Therapeutics Stock Sees RS Rating Jump To 82
Nurix Therapeutics CFO Hans van Houte sells $61k in shares
Nurix Therapeutics chief legal officer Ring sells $73k in stock
Nurix Therapeutics CSO Gwenn Hansen sells $81k in shares
Stifel raises Nurix stock price target to $35 on bexobrutideg potential
Piper Sandler raises Nurix stock price target to $35 on pivotal trial plans
H.C. Wainwright raises Nurix stock price target to $32 on financial results
Nurix stock price target raised to $30 from $28 at RBC Capital
Nurix Therapeutics, Inc. (NRIX) Reports Q4 Loss, Misses Revenue Estimates
Nurix earnings beat by $0.10, revenue fell short of estimates
Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Nurix Therapeutics chief legal officer Ring sells $69,273 in stock